IL1B and COVID-19: Particularly, the CRS-related cytokines, including IL-6, IL-1β, IL-10, IL-18, and IFN-γ, displayed progressive increase along disease severity from healthy controls to mild and severe patients (Supplementary Fig. 3b), highlighting the broad and strong inflammatory responses in severe COVID-19 patients.